• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于体内和体外数据对LoVo细胞肿瘤生长的指数-冈珀茨描述。

An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data.

作者信息

Demicheli R, Foroni R, Ingrosso A, Pratesi G, Soranzo C, Tortoreto M

机构信息

Division of Radiotherapy and Oncology ULSS 28, Legnago, Italy.

出版信息

Cancer Res. 1989 Dec 1;49(23):6543-6.

PMID:2819710
Abstract

The data of nine monolayer cultures, 48 multicellular spheroids, and 19 s.c. xenografts of LoVo cells were fitted, on an individual basis, by exponential and Gompertzian equations, respectively. The mean growth parameters alpha 0 (initial growth rate) and beta (retardation factor) of the three experimental systems presented a strong linear correlation alpha 0 = 6.88 beta + 0.56, r = 0.9843. This implies that, at the particular tumor size of 155 microns in diameter (mean +/- SD = 50-310 microns), the tumor growths described by Gompertzian curves (from spheroids as well as from s.c. xenografts) have the same growth rate as monolayer cultures. This occurrence strongly supports an exponential-Gompertzian growth model, where an exponential monolayer-like phase changes to a Gompertzian growth, controlled by environmental conditions, when the tumor size has reached a critical value.

摘要

分别对9个单层培养物、48个多细胞球体和19个LoVo细胞皮下异种移植的数据进行个体拟合,分别采用指数方程和冈珀茨方程。三个实验系统的平均生长参数α0(初始生长速率)和β(阻滞因子)呈现出强烈的线性相关性α0 = 6.88β + 0.56,r = 0.9843。这意味着,在直径为155微米的特定肿瘤大小(平均±标准差 = 50 - 310微米)时,由冈珀茨曲线描述的肿瘤生长(来自球体以及皮下异种移植)与单层培养物具有相同的生长速率。这种情况有力地支持了指数 - 冈珀茨生长模型,即当肿瘤大小达到临界值时,类似指数的单层样阶段会转变为由环境条件控制的冈珀茨生长。

相似文献

1
An exponential-Gompertzian description of LoVo cell tumor growth from in vivo and in vitro data.基于体内和体外数据对LoVo细胞肿瘤生长的指数-冈珀茨描述。
Cancer Res. 1989 Dec 1;49(23):6543-6.
2
The exponential-Gompertzian tumor growth model: data from six tumor cell lines in vitro and in vivo. Estimate of the transition point from exponential to Gompertzian growth and potential clinical implications.指数-冈珀茨肿瘤生长模型:来自六种肿瘤细胞系的体外和体内数据。指数生长向冈珀茨生长转变点的估计及其潜在临床意义。
Tumori. 1991 Jun 30;77(3):189-95. doi: 10.1177/030089169107700302.
3
The radiation response of a human colon adenocarcinoma grown in monolayer, as spheroids, and in nude mice.人结肠腺癌在单层培养、形成球体以及在裸鼠体内生长时的辐射反应。
Radiat Res. 1987 Oct;112(1):105-15.
4
[Kinetics of breast neoplasms].[乳腺肿瘤的动力学]
Minerva Med. 1994 Jan-Feb;85(1-2):7-16.
5
A comparative study of the effects of anthracycline derivatives on a human adenocarcinoma cell line (LoVo) grown as a monolayer and as spheroids.
Anticancer Res. 1988 May-Jun;8(3):369-73.
6
Human bladder carcinoma cells with an unusual pattern of in vitro growth: transition from nonproliferative spheroids to active monolayer growth upon interaction with tumor-derived fibroblasts.具有异常体外生长模式的人膀胱癌细胞:与肿瘤来源的成纤维细胞相互作用后,从非增殖性球体转变为活跃的单层生长。
Anticancer Res. 2000 Mar-Apr;20(2A):749-60.
7
Formation, growth and morphology of multicellular tumor spheroids from a human colon carcinoma cell line (LoVo).
Tumori. 1986 Oct 31;72(5):459-67. doi: 10.1177/030089168607200502.
8
Comparative Gompertzian analysis of alterations of tumor growth patterns.
Cancer Res. 1994 Aug 15;54(16):4385-92.
9
Mathematical model of simultaneous diffusion and binding of antitumor antibodies in multicellular human tumor spheroids.多细胞人肿瘤球体中抗肿瘤抗体同时扩散与结合的数学模型
Cancer Res. 1988 Jul 15;48(14):4032-7.
10
Gompertzian growth pattern correlated with phenotypic organization of colon carcinoma, malignant glioma and non-small cell lung carcinoma cell lines.戈姆珀茨生长模式与结肠癌、恶性胶质瘤和非小细胞肺癌细胞系的表型组织相关。
Cell Prolif. 2003 Apr;36(2):65-73. doi: 10.1046/j.1365-2184.2003.00259.x.

引用本文的文献

1
Delineating the evolutionary dynamics of cancer from theory to reality.描绘癌症从理论到现实的进化动力学。
Nat Cancer. 2020 Jun;1(6):580-588. doi: 10.1038/s43018-020-0079-6. Epub 2020 Jun 22.
2
Tumor Growth Rate After Nadir Is Associated With Survival in Patients With -Mutant Non-Small-Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.肿瘤在达到最低值后增长速度与接受表皮生长因子受体酪氨酸激酶抑制剂治疗的 - 突变型非小细胞肺癌患者的生存相关。
JCO Precis Oncol. 2021 Nov;5:1603-1610. doi: 10.1200/PO.21.00172.
3
Close Encounters of the Cell Kind: The Impact of Contact Inhibition on Tumour Growth and Cancer Models.
细胞的近距离接触:接触抑制对肿瘤生长和癌症模型的影响。
Bull Math Biol. 2020 Jan 22;82(2):20. doi: 10.1007/s11538-019-00677-y.
4
Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.用于指导精准癌症治疗的肿瘤体积增长率的自动化图像分析工具:以 EGFR 突变型非小细胞肺癌为例。
Eur J Radiol. 2018 Dec;109:68-76. doi: 10.1016/j.ejrad.2018.10.014. Epub 2018 Oct 23.
5
Modeling of the metabolic energy dissipation for restricted tumor growth.受限肿瘤生长的代谢能量耗散建模。
J Bioenerg Biomembr. 2017 Oct;49(5):381-389. doi: 10.1007/s10863-017-9723-y. Epub 2017 Aug 29.
6
Modeling multi-mutation and drug resistance: analysis of some case studies.多突变与耐药性建模:一些案例研究分析
Theor Biol Med Model. 2017 Mar 21;14(1):6. doi: 10.1186/s12976-017-0052-y.
7
A Model-Based Personalized Cancer Screening Strategy for Detecting Early-Stage Tumors Using Blood-Borne Biomarkers.一种基于模型的个性化癌症筛查策略,用于利用血液生物标志物检测早期肿瘤。
Cancer Res. 2017 May 15;77(10):2570-2584. doi: 10.1158/0008-5472.CAN-16-2904. Epub 2017 Mar 10.
8
Volumetric Tumor Response and Progression in EGFR-mutant NSCLC Patients Treated with Erlotinib or Gefitinib.接受厄洛替尼或吉非替尼治疗的EGFR突变型非小细胞肺癌患者的肿瘤体积反应与进展
Acad Radiol. 2016 Mar;23(3):329-36. doi: 10.1016/j.acra.2015.11.005. Epub 2016 Jan 8.
9
Initiate Tumors with Single Cell Spheres Formed in Serum-Containing Medium.用在含血清培养基中形成的单细胞球启动肿瘤。
J Cancer. 2015 Jul 28;6(9):901-12. doi: 10.7150/jca.11910. eCollection 2015.
10
Classical mathematical models for description and prediction of experimental tumor growth.用于描述和预测实验性肿瘤生长的经典数学模型。
PLoS Comput Biol. 2014 Aug 28;10(8):e1003800. doi: 10.1371/journal.pcbi.1003800. eCollection 2014 Aug.